FCRL5 and microscopic polyangiitis: In both rheumatoid arthritis (Owczarczyk et al., 2011) and granulomatosis with polyangiitis and microscopic polyangiitis (Owczarczyk et al., 2020), increased expression of FCRL5 was indicative of a positive response to rituximab.